IBDEI0M1 ; ; 06-AUG-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,10451,1,4,0)
 ;;=4^372.42
 ;;^UTILITY(U,$J,358.3,10451,2)
 ;;=^269027
 ;;^UTILITY(U,$J,358.3,10452,0)
 ;;=372.43^^44^565^77
 ;;^UTILITY(U,$J,358.3,10452,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10452,1,3,0)
 ;;=3^Pterygium,Central
 ;;^UTILITY(U,$J,358.3,10452,1,4,0)
 ;;=4^372.43
 ;;^UTILITY(U,$J,358.3,10452,2)
 ;;=^269029
 ;;^UTILITY(U,$J,358.3,10453,0)
 ;;=372.45^^44^565^80
 ;;^UTILITY(U,$J,358.3,10453,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10453,1,3,0)
 ;;=3^Pterygium,Recurrent
 ;;^UTILITY(U,$J,358.3,10453,1,4,0)
 ;;=4^372.45
 ;;^UTILITY(U,$J,358.3,10453,2)
 ;;=^269033
 ;;^UTILITY(U,$J,358.3,10454,0)
 ;;=372.53^^44^565^20
 ;;^UTILITY(U,$J,358.3,10454,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10454,1,3,0)
 ;;=3^Conjunctival Xerosis
 ;;^UTILITY(U,$J,358.3,10454,1,4,0)
 ;;=4^372.53
 ;;^UTILITY(U,$J,358.3,10454,2)
 ;;=^27544
 ;;^UTILITY(U,$J,358.3,10455,0)
 ;;=372.54^^44^565^16
 ;;^UTILITY(U,$J,358.3,10455,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10455,1,3,0)
 ;;=3^Conjunctival Concretions
 ;;^UTILITY(U,$J,358.3,10455,1,4,0)
 ;;=4^372.54
 ;;^UTILITY(U,$J,358.3,10455,2)
 ;;=^269038
 ;;^UTILITY(U,$J,358.3,10456,0)
 ;;=372.55^^44^565^19
 ;;^UTILITY(U,$J,358.3,10456,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10456,1,3,0)
 ;;=3^Conjunctival Pigmentations
 ;;^UTILITY(U,$J,358.3,10456,1,4,0)
 ;;=4^372.55
 ;;^UTILITY(U,$J,358.3,10456,2)
 ;;=^269039
 ;;^UTILITY(U,$J,358.3,10457,0)
 ;;=372.61^^44^565^13
 ;;^UTILITY(U,$J,358.3,10457,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10457,1,3,0)
 ;;=3^Conjunctiva,Granuloma
 ;;^UTILITY(U,$J,358.3,10457,1,4,0)
 ;;=4^372.61
 ;;^UTILITY(U,$J,358.3,10457,2)
 ;;=^269041
 ;;^UTILITY(U,$J,358.3,10458,0)
 ;;=372.64^^44^565^15
 ;;^UTILITY(U,$J,358.3,10458,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10458,1,3,0)
 ;;=3^Conjunctiva,Scarring
 ;;^UTILITY(U,$J,358.3,10458,1,4,0)
 ;;=4^372.64
 ;;^UTILITY(U,$J,358.3,10458,2)
 ;;=^269044
 ;;^UTILITY(U,$J,358.3,10459,0)
 ;;=372.72^^44^565^38
 ;;^UTILITY(U,$J,358.3,10459,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10459,1,3,0)
 ;;=3^Conjuntival Hemorrhage
 ;;^UTILITY(U,$J,358.3,10459,1,4,0)
 ;;=4^372.72
 ;;^UTILITY(U,$J,358.3,10459,2)
 ;;=^27538
 ;;^UTILITY(U,$J,358.3,10460,0)
 ;;=372.73^^44^565^18
 ;;^UTILITY(U,$J,358.3,10460,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10460,1,3,0)
 ;;=3^Conjunctival Edema
 ;;^UTILITY(U,$J,358.3,10460,1,4,0)
 ;;=4^372.73
 ;;^UTILITY(U,$J,358.3,10460,2)
 ;;=^263899
 ;;^UTILITY(U,$J,358.3,10461,0)
 ;;=372.75^^44^565^17
 ;;^UTILITY(U,$J,358.3,10461,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10461,1,3,0)
 ;;=3^Conjunctival Cysts
 ;;^UTILITY(U,$J,358.3,10461,1,4,0)
 ;;=4^372.75
 ;;^UTILITY(U,$J,358.3,10461,2)
 ;;=^269049
 ;;^UTILITY(U,$J,358.3,10462,0)
 ;;=372.89^^44^565^14
 ;;^UTILITY(U,$J,358.3,10462,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10462,1,3,0)
 ;;=3^Conjunctiva,Lymphangiectasis
 ;;^UTILITY(U,$J,358.3,10462,1,4,0)
 ;;=4^372.89
 ;;^UTILITY(U,$J,358.3,10462,2)
 ;;=^321988
 ;;^UTILITY(U,$J,358.3,10463,0)
 ;;=376.12^^44^565^73
 ;;^UTILITY(U,$J,358.3,10463,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10463,1,3,0)
 ;;=3^Orbital Myositis
 ;;^UTILITY(U,$J,358.3,10463,1,4,0)
 ;;=4^376.12
 ;;^UTILITY(U,$J,358.3,10463,2)
 ;;=^190915
 ;;^UTILITY(U,$J,358.3,10464,0)
 ;;=376.32^^44^565^72
 ;;^UTILITY(U,$J,358.3,10464,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10464,1,3,0)
 ;;=3^Orbital Hemorrhage
 ;;^UTILITY(U,$J,358.3,10464,1,4,0)
 ;;=4^376.32
 ;;^UTILITY(U,$J,358.3,10464,2)
 ;;=^269185
 ;;^UTILITY(U,$J,358.3,10465,0)
 ;;=376.35^^44^565^81
 ;;^UTILITY(U,$J,358.3,10465,1,0)
 ;;=^358.31IA^4^2
 ;;
 ;;$END ROU IBDEI0M1
